Internal Medicine · Philadelphia, PA
NPI
1548228489
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1740 South St, Ste 300
Philadelphia, PA, 19146
Phone (215) 732-0876
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
805 services
Medicare patients, 2024
208
Average age 72
Drug cost, 2024
$1.3M
12,418 prescriptions
Company payments, 2025
$412
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wilbert R Warren was code 99213 (office e&m - established), 332 times for 179 patients. In total Wilbert R Warren billed 805 services in 29 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 332 | 179 | $59.90 | $20K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 134 | 134 | $132.70 | $18K |
| 90662 Vaccine Product | Office | 68 | 67 | $81.24 | $5,524 |
| G0008 Administration of influenza virus vaccine | Office | 68 | 66 | $33.28 | $2,263 |
| 82962 Clinical Chemistry | Office | 40 | 27 | $3.21 | $128 |
| 99214 Office E&M - Established | Office | 21 | 19 | $81.28 | $1,707 |
| 99212 Office E&M - Established | Office | 19 | 13 | $36.10 | $686 |
| 93000 Electrocardiogram | Office | 16 | 15 | $10.98 | $176 |
| G0009 Administration of pneumococcal vaccine | Office | 15 | 15 | $33.24 | $499 |
| 90677 Vaccine Product | Office | 12 | 12 | $289.02 | $3,468 |
By year: 2022 $65K for 1,061 services; 2023 $62K for 905 services; 2024 $57K for 805 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 40 | 27 | $3.21 | $128 |
Medicare prescription drug claims, 2024
In 2024, the drug Wilbert R Warren prescribed most often to Medicare patients was Amlodipine Besylate, with 668 prescriptions and refills. In total Wilbert R Warren wrote 12,418 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 668 | 1,861 | 197 | $4,401 |
| Atorvastatin Calcium Generic | 647 | 1,713 | 186 | $7,391 |
| Losartan Potassium Generic | 497 | 1,362 | 149 | $5,786 |
| Rosuvastatin Calcium Generic | 349 | 1,017 | 121 | $8,052 |
| Metoprolol Succinate Generic | 348 | 966 | 106 | $5,421 |
| Gabapentin Generic | 328 | 668 | 99 | $4,802 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 286 | 394 | 92 | $13K |
| Furosemide Generic | 285 | 658 | 88 | $892 |
| Pantoprazole Sodium Generic | 249 | 609 | 74 | $2,208 |
| Metformin Hcl Generic | 245 | 680 | 77 | $2,291 |
| Lisinopril Generic | 239 | 653 | 72 | $2,109 |
| Omeprazole Generic | 214 | 556 | 63 | $2,366 |
| Famotidine Generic | 207 | 506 | 70 | $1,600 |
| Fluticasone Propionate Generic | 204 | 399 | 75 | $3,232 |
| Hydrochlorothiazide Generic | 189 | 530 | 66 | $790 |
Brand drugs: 1,424 claims; generic drugs: 10,913 claims; opioid claims: 417.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wilbert R Warren $412 ($412 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $96.34.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $96.34 |
| Novo Nordisk Inc NVO | 5 | $95.84 |
| GlaxoSmithKline, LLC. GSK | 3 | $50.47 |
| Shield Therapeutics Inc STX.L | 1 | $35.16 |
| Abbott Laboratories ABT | 1 | $24.79 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $21.88 |
| OPKO Pharmaceuticals, LLC | 1 | $20.48 |
| Lilly USA, LLC LLY | 1 | $19.7 |
| Eisai Inc. 4523.T | 1 | $16.02 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $15.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.